Jeffrey S. Sager, MD Medical Corporation

Santa Barbara, California 93105

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension

Studies at this site

• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) — Completed